Adoptive immunotherapy for cancer: building on success (original) (raw)

• Boon, T., Coulie, P. G., Van Den Eynde, B. J. & Van Der, B. P. Human T cell responses against melanoma. Annu. Rev. Immunol. 24, 175–208 (2006).
  Article CAS PubMed Google Scholar
• Rosenberg, S. A. Progress in human tumour immunology and immunotherapy. Nature 411, 380–384 (2001).
  Article CAS PubMed Google Scholar
• Pardoll, D. M. & Topalian, S. L. The role of CD4+ T cell responses in antitumour immunity. Curr. Opin. Immunol. 10, 588–594 (1998).
  Article CAS PubMed Google Scholar
• Wang, R. F., Peng, G. & Wang, H. Y. Regulatory T cells and Toll-like receptors in tumour immunity. Semin. Immunol. 18, 136–42 (2006).
  Article CAS PubMed Google Scholar
• Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunol. 6, 345–352 (2005).
  Article CAS Google Scholar
• Lenschow, D. J., Walunas, T. L. & Bluestone, J. A. CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14, 233–258 (1996).
  Article CAS PubMed Google Scholar
• Chambers, C. A. & Allison, J. P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396–404 (1997).
  Article CAS PubMed Google Scholar
• Klebanoff, C. A. et al. IL-15 enhances the in vivo antitumour activity of tumour-reactive CD8+ T cells. Proc. Natl Acad. Sci. USA 101, 1969–1974 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Li, Y., Bleakley, M. & Yee, C. IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. J. Immunol. 175, 2261–2269 (2005).
  Article CAS PubMed Google Scholar
• Rosenberg, S. A., Yang, J. C. & Restifo, N. P. Cancer immunotherapy: moving beyond current vaccines. Nature Med. 10, 909–915 (2004). This paper highlights the ineffectiveness of current cancer vaccine strategies and the need to develop alternative immunotherapeutic strategies.
  Article CAS PubMed Google Scholar
• Waldmann, T. A. Effective cancer therapy through immunomodulation. Annu. Rev. Med. 57, 65–81 (2006).
  Article CAS PubMed Google Scholar
• Klebanoff, C. A., Khong, H. T., Antony, P. A., Palmer, D. C. & Restifo, N. P. Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumour immunotherapy. Trends Immunol. 26, 111–117 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Schreiber, H., Wu, T. H., Nachman, J. & Kast, W. M. Immunodominance and tumour escape. Semin. Cancer Biol. 12, 25–31 (2002).
  Article CAS PubMed Google Scholar
• Khong, H. T. & Restifo, N. P. Natural selection of tumour variants in the generation of 'tumour escape' phenotypes. Nature Immunol. 3, 999–1005 (2002).
  Article CAS Google Scholar
• Dudley, M. E. & Rosenberg, S. A. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nature Rev. Cancer 3, 666–675 (2003).
  Article CAS Google Scholar
• Yee, C. et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumour effect of transferred T cells. Proc. Natl Acad. Sci. USA 99, 16168–16173 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Bollard, C. M. et al. Cytotoxic T lymphocyte therapy for Epstein–Barr virus+ Hodgkin's disease. J. Exp. Med. 200, 1623–1633 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Rosenberg, S. A. et al. Treatment of patients with metastatic melanoma with autologous tumour-infiltrating lymphocytes and interleukin 2. J. Natl Cancer Inst. 86, 1159–1166 (1994).
  Article CAS PubMed Google Scholar
• Cheever, M. A., Greenberg, P. D. & Fefer, A. Specificity of adoptive chemoimmunotherapy of established syngeneic tumours. J. Immunol. 125, 711–714 (1980). This pioneering paper reports the increased antitumour efficacy of tumour-reactive T cells in a lymphodepleted host.
  CAS PubMed Google Scholar
• North, R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumour depends on elimination of tumour-induced suppressor T cells. J. Exp. Med. 155, 1063–1074 (1982).
  Article CAS PubMed Google Scholar
• Dudley, M. E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumour lymphocytes. Science 298, 850–854 (2002). This paper describes the first successful clinical trail of ACT with TILs following non-myeloablative chemotherapy for the treatment of patients with melanoma.
  Article CAS PubMed PubMed Central Google Scholar
• Dudley, M. E. et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23, 2346–2357 (2005).
  Article CAS PubMed Google Scholar
• Walker, M. R. et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J. Clin. Invest 112, 1437–1443 (2003).
  Article CAS PubMed Google Scholar
• Antony, P. A. et al. CD8+ T cell immunity against a tumour/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol. 174, 2591–2601 (2005). This paper elucidates the role of CD4+CD25+ T cells in preventing an otherwise productive antitumour immune response against an established syngeneic tumour.
  Article CAS PubMed Google Scholar
• Woo, E. Y. et al. Regulatory CD4+CD25+T cells in tumours from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61, 4766–4772 (2001).
  CAS PubMed Google Scholar
• Viguier, M. et al. Foxp3 expressing CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 173, 1444–1453 (2004).
  Article CAS PubMed Google Scholar
• Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med. 10, 942–949 (2004). This paper was the first to correlate the presence of T Reg cells and clinical outcome in patients with cancer.
  Article CAS PubMed Google Scholar
• Sato, E. et al. Intraepithelial CD8+ tumour-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favourable prognosis in ovarian cancer. Proc. Natl Acad. Sci. USA 102, 18538–18543 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Powell, D. J. Jr., Parker, L. L. & Rosenberg, S. A. Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples. J. Immunother. 28, 403–411 (2005).
  Article PubMed PubMed Central Google Scholar
• Zhang, H. et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nature Med. 11, 1238–1243 (2005).
  Article CAS PubMed Google Scholar
• Ahmadzadeh, M. & Rosenberg, S. A. IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients. Blood 107, 2409–2414 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kronenberg, M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 877–900 (2005).
  Article CAS PubMed Google Scholar
• Beilke, J. N., Kuhl, N. R., Van Kaer, L. & Gill, R. G. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nature Med. 11, 1059–1065 (2005).
  Article CAS PubMed Google Scholar
• Bronte, V. & Zanovello, P. Regulation of immune responses by L-arginine metabolism. Nature Rev. Immunol. 5, 641–654 (2005).
  Article CAS Google Scholar
• Rodriguez, P. C. et al. Arginase I production in the tumour microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64, 5839–5849 (2004).
  Article CAS PubMed Google Scholar
• Bronte, V. et al. Boosting antitumour responses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med. 201, 1257–1268 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Seung, L. P., Rowley, D. A., Dubey, P. & Schreiber, H. Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumour rejection. Proc. Natl Acad. Sci. USA 92, 6254–6258 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Goldrath, A. W., Bogatzki, L. Y. & Bevan, M. J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192, 557–564 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Cho, B. K., Rao, V. P., Ge, Q., Eisen, H. N. & Chen, J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192, 549–556 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ernst, B., Lee, D. S., Chang, J. M., Sprent, J. & Surh, C. D. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11, 173–181 (1999).
  Article CAS PubMed Google Scholar
• Dummer, W., Ernst, B., LeRoy, E., Lee, D. & Surh, C. Autologous regulation of naive T cell homeostasis within the T cell compartment. J. Immunol. 166, 2460–2468 (2001).
  Article CAS PubMed Google Scholar
• Gattinoni, L. et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumour-specific CD8+ T cells. J. Exp. Med. 202, 907–912 (2005). This paper establishes the direct role of the endogenous homeostatic cytokines IL-7 and IL-15 in increasing CD8+T-cell effector functions in a lymphodepleted environment.
  Article CAS PubMed PubMed Central Google Scholar
• Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefrancois, L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature Immunol. 1, 426–432 (2000).
  Article CAS Google Scholar
• Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. & Marrack, P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288, 675–678 (2000).
  Article CAS PubMed Google Scholar
• Tan, J. T. et al. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 195, 1523–1532 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kieper, W. C. et al. Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells. J. Exp. Med. 195, 1533–1539 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Marks-Konczalik, J. et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl Acad. Sci. USA 97, 11445–11450 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Overwijk, W. W. et al. Tumour regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J. Exp. Med. 198, 569–580 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, L. X. et al. Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumour regression and editing. Cancer Res. 65, 10569–10577 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Prlic, M., Blazar, B. R., Farrar, M. A. & Jameson, S. C. In vivo survival and homeostatic proliferation of natural killer cells. J. Exp. Med. 197, 967–976 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Koka, R. et al. Interleukin (IL)-15Rα-deficient natural killer cells survive in normal but not IL-15R α-deficient mice. J. Exp. Med. 197, 977–984 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Furtado, G. C., Curotto de Lafaille, M. A., Kutchukhidze, N. & Lafaille, J. J. Interleukin 2 signalling is required for CD4+regulatory T cell function. J. Exp. Med. 196, 851–857 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunol. 6, 1142–1151 (2005).
  Article CAS Google Scholar
• Antony, P. A. et al. Interleukin-2 dependent mechanisms of tolerance and immunity in vivo. J. Immunol. (in the press) References 53 and 54 highlight the role of IL-2 in maintaining the homeostasis and competitive fitness of T Reg cells in vivo.
• Kohm, A. P. et al. Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J. Immunol. 176, 3301–3305 (2006).
  Article CAS PubMed Google Scholar
• de la, R. M., Rutz, S., Dorninger, H. & Scheffold, A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480–2488 (2004).
  Article CAS Google Scholar
• Russo, V. et al. Dendritic cells acquire the MAGE-3 human tumour antigen from apoptotic cells and induce a class I-restricted T cell response. Proc. Natl Acad. Sci. USA 97, 2185–2190 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, S., Konopa, J., Zhou, D. & Thompson, J. Expression of TNFα by CD3+ and F4/80+ cells following irradiation preconditioning and allogeneic spleen cell transplantation. Bone Marrow Transplant. 33, 359–365 (2004).
  Article CAS PubMed Google Scholar
• Zhang, Y., Louboutin, J. P., Zhu, J., Rivera, A. J. & Emerson, S. G. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109, 1335–1344 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hill, G. R. et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90, 3204–3213 (1997).
  Article CAS PubMed Google Scholar
• Sherman, M. L., Datta, R., Hallahan, D. E., Weichselbaum, R. R. & Kufe, D. W. Regulation of tumour necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J. Clin. Invest. 87, 1794–1797 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Xun, C. Q., Thompson, J. S., Jennings, C. D., Brown, S. A. & Widmer, M. B. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83, 2360–2367 (1994).
  Article CAS PubMed Google Scholar
• Rigby, S. M., Rouse, T. & Field, E. H. Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells. Blood 101, 2024–2032 (2003).
  Article CAS PubMed Google Scholar
• Kedl, R. M. et al. T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 192, 1105–1113 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Gattinoni, L. et al. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumour efficacy of adoptively transferred CD8+ T cells. J. Clin. Invest. 115, 1616–1626 (2005). This paper elucidates the gene-expression, phenotypic and functional profiles of CD8+ T cells that mediate a highly effective antitumour response in vivo.
  Article CAS PubMed PubMed Central Google Scholar
• Robbins, P. F. et al. Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J. Immunol. 173, 7125–7130 (2004).
  Article CAS PubMed Google Scholar
• Huang, J. et al. Survival, persistence, and progressive differentiation of adoptively transferred tumour-reactive T cells associated with tumour regression. J. Immunother. 28, 258–267 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, J. et al. Telomere length of transferred lymphocytes correlates with in vivo persistence and tumour regression in melanoma patients receiving cell transfer therapy. J. Immunol. 175, 7046–7052 (2005).
  Article CAS PubMed Google Scholar
• Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nature Med. 8, 379–385 (2002). This paper shows the progressive differentiation of CD8+ T cells from patients with acute and chronic viral infections.
  Article CAS PubMed Google Scholar
• Lanzavecchia, A. & Sallusto, F. Progressive differentiation and selection of the fittest in the immune response. Nature Rev. Immunol. 2, 982–987 (2002).
  Article CAS Google Scholar
• Papagno, L. et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 Infection. PLoS. Biol. 2, e20 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Willinger, T., Freeman, T., Hasegawa, H., McMichael, A. J. & Callan, M. F. Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J. Immunol. 175, 5895–5903 (2005).
  Article CAS PubMed Google Scholar
• Lanzavecchia, A. & Sallusto, F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290, 92–97 (2000).
  Article CAS PubMed Google Scholar
• Fearon, D. T., Manders, P. & Wagner, S. D. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293, 248–250 (2001).
  Article CAS PubMed Google Scholar
• Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature Immunol. 4, 225–234 (2003).
  Article CAS Google Scholar
• Wang, L. X. et al. Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells. J. Transl. Med. 2, 41 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Sussman, J. J., Parihar, R., Winstead, K. & Finkelman, F. D. Prolonged culture of vaccine-primed lymphocytes results in decreased antitumour killing and change in cytokine secretion. Cancer Res. 64, 9124–9130 (2004).
  Article CAS PubMed Google Scholar
• Chen, B. J., Cui, X., Sempowski, G. D., Liu, C. & Chao, N. J. Transfer of allogeneic CD62L− memory T cells without graft-versus-host disease. Blood 103, 1534–1541 (2004).
  Article CAS PubMed Google Scholar
• Bondanza, A. et al. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107, 1828–1836 (2006).
  Article CAS PubMed Google Scholar
• Kaech, S. M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nature Immunol. 4, 1191–1198 (2003). This paper prospectively identifies the sub-population of antigen-specific effector CD8+ T cells expressing IL-7Rα that will persist as a pool of memory T cells.
  Article CAS Google Scholar
• Klebanoff, C. A. et al. Central memory self/tumour-reactive CD8+ T cells confer superior antitumour immunity compared with effector memory T cells. Proc. Natl Acad. Sci. USA 102, 9571–9576 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Dudley, M. E. et al. A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumour antigen-specific T lymphocytes in patients with metastatic melanoma. J. Immunother. 25, 243–251 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, H., Li, F., Gordon, J. R. & Xiang, J. Synergistic enhancement of antitumour immunity with adoptively transferred tumour-specific CD4+ and CD8+ T cells and intratumoural lymphotactin transgene expression. Cancer Res. 62, 2043–2051 (2002).
  CAS PubMed Google Scholar
• Kershaw, M. H. et al. Redirecting migration of T cells to chemokine secreted from tumours by genetic modification with CXCR2. Hum. Gene Ther. 13, 1971–1980 (2002).
  Article CAS PubMed Google Scholar
• Kagamu, H., Touhalisky, J. E., Plautz, G. E., Krauss, J. C. & Shu, S. Isolation based on L-selectin expression of immune effector T cells derived from tumour-draining lymph nodes. Cancer Res. 56, 4338–4342 (1996).
  CAS PubMed Google Scholar
• Speiser, D. E. et al. Self antigens expressed by solid tumours do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J. Exp. Med. 186, 645–653 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Powell D. J. Jr, Dudley, M. E., Robbins, P. F. & Rosenberg, S. A. Transition of late stage effector T cells to CD27+ CD28+ tumour-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 105, 241–250 (2005).
  Article CAS PubMed Google Scholar
• Acuto, O. & Michel, F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nature Rev. Immunol. 3, 939–951 (2003).
  Article CAS Google Scholar
• Topp, M. S. et al. Restoration of CD28 expression in CD28− CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production. J. Exp. Med. 198, 947–955 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hendriks, J. et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nature Immunol. 1, 433–440 (2000).
  Article CAS Google Scholar
• Hendriks, J., Xiao, Y. & Borst, J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198, 1369–1380 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Arens, R. et al. Tumour rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J. Exp. Med. 199, 1595–1605 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Huang J. et al. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. J. Immunol. (in the press).
• Ochsenbein, A. F. et al. CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J. Exp. Med. 200, 1407–1417 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Dubois, S., Mariner, J., Waldmann, T. A. & Tagaya, Y. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity. 17, 537–547 (2002).
  Article CAS PubMed Google Scholar
• Liu, K. & Rosenberg, S. A. Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent. J. Immunother. 26, 190–201 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hodes, R. J., Hathcock, K. S. & Weng, N. P. Telomeres in T and B cells. Nature Rev. Immunol. 2, 699–706 (2002).
  Article CAS Google Scholar
• Speiser, D. E. & Romero, P. Toward improved immunocompetence of adoptively transferred CD8+ T cells. J. Clin. Invest 115, 1467–1469 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Refaeli, Y., Van Parijs, L., London, C. A., Tschopp, J. & Abbas, A. K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. 8, 615–623 (1998).
  Article CAS PubMed Google Scholar
• Teague, R. M. et al. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumours. Nature Med. 12, 335–341 (2006).
  Article CAS PubMed Google Scholar
• Opferman, J. T. et al. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426, 671–676 (2003).
  Article CAS PubMed Google Scholar
• Hsu, C. et al. Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine. J. Immunol. 175, 7226–7234 (2005).
  Article CAS PubMed Google Scholar
• Liu, S., Riley, J. L., Rosenberg, S. A. & Parkhurst, M. R. Comparison of common γ-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumour-reactive T lymphocytes for adoptive cell transfer therapy. J. Immunother. (in the press).
• Powell, D. J. Jr. & Rosenberg, S. A. Phenotypic and functional maturation of tumour antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination. J. Immunother. 27, 36–47 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Pittet, M. J. et al. High frequencies of naive Melan-A/MART-1-specific CD8+ T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 190, 705–715 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Zippelius, A. et al. Effector function of human tumour-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res. 64, 2865–2873 (2004).
  Article CAS PubMed Google Scholar
• Dutoit, V. et al. Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-A peptide multimer+ CD8+ T cells in humans. J. Exp. Med. 196, 207–216 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Roszkowski, J. J. et al. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res. 65, 1570–1576 (2005).
  Article CAS PubMed Google Scholar
• Hughes, M. S. et al. Transfer of a TCR gene derived from a patient with a marked antitumour response conveys highly active T-cell effector functions. Hum. Gene Ther. 16, 457–472 (2005).
  Article CAS PubMed Google Scholar
• Zhao, Y. et al. Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumour cell lines. J. Immunol. 174, 4415–4423 (2005).
  Article CAS PubMed Google Scholar
• Kuball, J. et al. Cooperation of human tumour-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2. 1-specific TCR. Immunity. 22, 117–129 (2005). This paper describes an effective way to generate highly avid TCRs specific for self/tumour antigens using HLA-A2-transgenic mice.
  Article CAS PubMed Google Scholar
• Cohen, C. J. et al. Recognition of fresh human tumour by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. J. Immunol. 175, 5799–5808 (2005).
  Article CAS PubMed Google Scholar
• Li, Y. et al. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nature Biotechnol. 23, 349–354 (2005).
  Article CAS Google Scholar
• Cavalieri, S. et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 102, 497–505 (2003).
  Article CAS PubMed Google Scholar
• Schmitt, T. M. et al. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nature Immunol. 5, 410–417 (2004).
  Article CAS Google Scholar
• Clark, R. A., Yamanaka, K. I., Bai, M., Dowgiert, R. & Kupper, T. S. Human skin cells support thymus-independent T cell development. J. Clin. Invest. 115, 3239–3249 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ishikawa, F. et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain (null) mice. Blood 106, 1565–1573 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Schlissel, M. S. Regulating antigen-receptor gene assembly. Nature Rev. Immunol. 3, 890–899 (2003).
  Article CAS Google Scholar
• Willemsen, R. A. et al. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther. 7, 1369–1377 (2000).
  Article CAS PubMed Google Scholar
• Pinthus, J. H. et al. Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes. J. Clin. Invest 114, 1774–1781 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Carding, S. R. & Egan, P. J. γδ T cells: functional plasticity and heterogeneity. Nature Rev. Immunol. 2, 336–345 (2002).
  Article CAS Google Scholar
• Kershaw, M. H., Teng, M. W., Smyth, M. J. & Darcy, P. K. Supernatural T cells: genetic modification of T cells for cancer therapy. Nature Rev. Immunol. 5, 928–940 (2005).
  Article CAS Google Scholar
• Charo, J. et al. Bcl-2 overexpression enhances tumour-specific T-cell survival. Cancer Res. 65, 2001–2008 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Palmer, D. C. et al. Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumour destruction. J. Immunol. 173, 7209–7216 (2004).
  Article CAS PubMed Google Scholar
• Hwang, L. N., Yu, Z., Palmer, D. C. & Restifo, N. P. The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumour. Cancer Res. 66, 1132–1138 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Rapoport, A. P. et al. Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nature Med. 11, 1230–1237 (2005).
  Article CAS PubMed Google Scholar
• Ichii, H. et al. Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells. Nature Immunol. 3, 558–563 (2002).
  Article CAS Google Scholar
• Ichii, H., Sakamoto, A., Kuroda, Y. & Tokuhisa, T. Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T cells. J. Immunol. 173, 883–891 (2004).
  Article CAS PubMed Google Scholar
• Manders, P. M. et al. Inaugural article: BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes. Proc. Natl Acad. Sci. USA 102, 7418–7425 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Willinger, T. et al. Human naive CD8 T cells downregulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. J. Immunol. 176, 1439–1446 (2006).
  Article CAS PubMed Google Scholar
• Fujita, N. et al. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119, 75–86 (2004). This paper represents the proof of principle that lymphocyte differentiation states can be reverted by manipulation of key transcriptional factors.
  Article CAS PubMed Google Scholar
• Wrzesinski, C. & Restifo, N. P. Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumour immunotherapy. Curr. Opin. Immunol. 17, 195–201 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Dannull, J. et al. Enhancement of vaccine-mediated antitumour immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest 115, 3623–3633 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Attia, P., Maker, A. V., Haworth, L. R., Rogers-Freezer, L. & Rosenberg, S. A. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J. Immunother. 28, 582–592 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Attia, P. et al. Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. J. Immunother. 29, 208–214 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Valencia, X. et al. TNF down-modulates the function of human CD4+CD25hi T regulatory cells. Blood 14 Mar 2006 (doi:1182/blood-2005-11-4567).
• Atkins, M. B., Kunkel, L., Sznol, M. & Rosenberg, S. A. High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J. Sci. Am. 6, S11–S14 (2000).
  PubMed Google Scholar
• Boyman, O., Kovar, M., Rubinstein, M., Surh, C. D. & Sprent, J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 15 Feb 2006 (doi:10.1126/science.1122927).
• Speiser, D. E. et al. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J. Clin. Invest. 115, 739–746 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Kallies, A. et al. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nature Immunol. 26 Mar 2006 (doi:1038/ni1321).
• Martins, G. A. et al. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nature Immunol. 26 Mar 2006 (doi:1038/ni1320).